Login

Richard Garr, President & CEO of Neuralstem Inc 00:00:00

Share On Facebook Share On Twitter

Neuralstem Inc

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Multicom's Vanadium Ventures: Shawn's Update at One-to-One Conference
00:10:00
Aegon CEO Discusses Commercial Momentum and Risk Management Amid Market Volatility | Lard Friese, CEO , Aegon N.V.
00:10:00
Critical Metal Portfolio Overview in Namibia
00:10:00
PrairiesCan: Supporting Economic Growth and Innovation Across the Prairies.
00:10:00
Dr. Dirk Markus Discusses Aurelius Group's Approach and Opportunities | Dr. Dirk Markus, Chairman , AURELIUS Group.
00:10:00
Plateau Uranium: Leading Lithium-Uranium Exploration in Peru, Fueling Green Energy Future
00:10:00
Vantea Smart’s Successful Market Debut and Focus on Cybersecurity | Simone Veglioni, CEO , Vantea Smart SPA.
00:10:00
Chris Flowers on Financial Crises: Reflections and Future Risks | Chris Flowers, CEO, J.C. Flowers & Co.
00:10:00
Global Markets Rebound: Invesco's Asia-Pacific Journey Post-Pandemic | Andrew Schlossberg , CEO , Invesco.
00:10:00
Floor Talk series featuring executive interviews with Jake Kornreich, CFO, and Jim Fish, President, garnering 107 views in the last 8 hours.|David S. Graziosi has served as a director of Allison Transmission Holdings Inc
00:10:00
Rapyd Ventures is the investment arm of Rapyd payments|Joel Yarbrough,Managing Director,Rapyd Ventures
00:10:00
Darren Gordon Discusses Centaurus Metals' Jaguar Nickel Project in Brazil

© 2026 Nehu